{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:32:12Z","timestamp":1789475532085,"version":"build-2803163510"},"reference-count":62,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Obesity"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Pregnancy during or soon after treatment with weight loss medication, particularly glucagon\u2010like peptide\u20101 receptor agonists (GLP\u20101 RAs), is contraindicated due to potential teratogenicity. The aim of this scoping review is to investigate what is known about the use of weight loss medication in women of childbearing age in relation to reproductive health outcomes, focusing on the three medications licenced in the United Kingdom at the time of the search. A systematic search of studies that assessed reproductive health outcomes in women taking either orlistat, liraglutide or semaglutide was undertaken in July 2023 and updated in January 2024 across MEDLINE, Embase, CINAHL, Scopus, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>, PROSPERO, Epistemonikos and OpenGrey. Studies focused on polycystic ovarian syndrome, diabetes or animals were excluded. Titles and abstracts were screened, and data from included articles were extracted. After removal of duplicates, 341 titles remained, of which 318 were excluded. Of the final 18 articles included, there were five interventional trials, one retrospective case\u2010control study, six narrative reviews, two systematic reviews, three systematic review protocols and one registry protocol yet to start recruitment. All five interventional trials involved orlistat given preconceptionally, showing no improvement in live birth rate, despite improvement in reproductive hormone levels. There were no studies with primary data about GLP\u20101 RAs. There were no qualitative studies. There is an absence of primary data about the role of GLP\u20101 RAs on the reproductive health of women of childbearing age without polycystic ovarian syndrome. Future research should explore short\u2010 and long\u2010term effects on reproductive health, pregnancy outcomes and experiences.<\/jats:p>","DOI":"10.1111\/cob.12690","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:34:55Z","timestamp":1719894895000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["What is known about the use of weight loss medication in women with overweight\/obesity\u00a0on fertility and reproductive health outcomes? A scoping review"],"prefix":"10.1111","volume":"14","author":[{"given":"Kate","family":"Maslin","sequence":"first","affiliation":[{"name":"School of Nursing and Midwifery University of Plymouth  Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab","family":"Alkutbe","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery University of Plymouth  Plymouth UK"},{"name":"Research and Innovation Department Saudi Patient Safety Centre  Riyadh Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Gilbert","sequence":"additional","affiliation":[{"name":"NHS Trust  Treliske UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8927-1266","authenticated-orcid":false,"given":"Jonathan","family":"Pinkney","sequence":"additional","affiliation":[{"name":"Peninsula Medical School University of Plymouth  Plymouth UK"},{"name":"Derriford Hospital Plymouth Hospitals NHS Trust  Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Shawe","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery University of Plymouth  Plymouth UK"},{"name":"NHS Trust  Treliske UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.3635"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13325"},{"key":"e_1_2_9_4_1","volume-title":"NHS Maternity Care for Women with a Body Mass Index of 30 Kg\/m2 or above Births between 1 April 2015 and 31 March 2017 in England, Wales and Scotland","author":"National Maternity & Perinatal Audit","year":"2021"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30311-8"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004282"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13326"},{"key":"e_1_2_9_8_1","unstructured":"British National Formulary.Orlistat.2018. Accessed January 5 2023.https:\/\/bnf.nice.org.uk\/drug\/orlistat.html"},{"key":"e_1_2_9_9_1","unstructured":"Medicines and Healthcare products Regulatory Agency.Summary of Product Characteristics: Wegovy 2.4m flextouch soluttion for injection in pre\u2010filled pen. Accessed January 5 2024.https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/e6c387e60fccee1f0940c4e9f0c44714f01c32d3"},{"key":"e_1_2_9_10_1","unstructured":"Medicines and Healthcare products Regulatory Agency.Summary of Product Characteristics: Saxenda 6mg\/ml solution for injection in pre\u2010filled pen. Accessed January 5 2024.https:\/\/mhraproducts4853.blob.core.windows.net\/docs\/367b466fd252f426e9540269fed8b66b9e858be4"},{"key":"e_1_2_9_11_1","volume-title":"Semaglutide for Managing Overweight and Obesity. Technology Appraisal Guidance [TA875]","author":"National Institute for Health and Care Excellence","year":"2023"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15386"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1215356"},{"key":"e_1_2_9_14_1","volume-title":"Overweight, Obesity & Contraception","author":"The Faculty of Sexual and Reproductive Healthcare","year":"2019"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2020.8683"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12902\u2010023\u201001500\u20105"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-018-1140-6"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12726"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000446951"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15092"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijamr.ijamr_91_23"},{"key":"e_1_2_9_22_1","volume-title":"The Joanna Briggs Institute Reviewers' Manual 2015 Methodology for JBI Scoping Reviews","author":"JBI","year":"2015"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/1364557032000119616"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_2_9_26_1","first-page":"20","article-title":"Use of orlistat (xenical) in the treatment of women with obesity and disorders of menstrual cycle","volume":"139","author":"Totoian ES","year":"2006","journal-title":"Georgian Med News"},{"issue":"2","key":"e_1_2_9_27_1","first-page":"432","article-title":"Orlistat (the Lipase Inhibitor) therapy in overweight and obese subfertile women","volume":"26","author":"Rahman D","year":"2017","journal-title":"Mymensingh Med J"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab340"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003883"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.21608\/amj.2022.230460"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2028769"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776795"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13669-023-00350-1"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2023.2194636"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz019"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000835"},{"issue":"3","key":"e_1_2_9_37_1","article-title":"Pharmacological and non\u2010pharmacological strategies for obese women with subfertility","volume":"3","author":"Taghavi SA","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_38_1","unstructured":"A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy.ClinicalTrials.govID NCT05872022.2023. Accessed January 5 2024.https:\/\/beta.clinicaltrials.gov\/study\/NCT05872022"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0175"},{"key":"e_1_2_9_40_1","unstructured":"Nana ma aqjwrq.Effect of preconception intervention on pregnancy outcome in obese\/overweight women undergoing IVF\/ICSI \u2010 a systematic review and meta\u2010analysis.2022. Accessed January 5 2024.https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=326403"},{"key":"e_1_2_9_41_1","unstructured":"Jia GuoYG.Efficacy of weight\u2010loss interventions for improving fertility in overweight or obese infertile women: a systematic review and meta\u2010analysis.2023. Accessed January 5 2024.https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=421091"},{"key":"e_1_2_9_42_1","unstructured":"Ruiz\u2010Gonz\u00e1lezD Martinez ForteS Hern\u00e1ndez\u2010Mart\u00ednezA et al.Effects of pharmacological and\/or weight loss strategies on hormonal profile in women at fertile age with overweight or obesity. A systematic review and network meta\u2010analysis.2022. Accessed January 5 2024.https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=311023"},{"key":"e_1_2_9_43_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072686","article-title":"Effectiveness and safety of drugs for obesity","volume":"384","author":"Henderson K","year":"2024","journal-title":"BMJ"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52031"},{"key":"e_1_2_9_45_1","volume-title":"Statistics on Obesity, Physical Activity and Diet, England 2021","author":"Office for National Statistics","year":"2021"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0258"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.158"},{"key":"e_1_2_9_48_1","volume-title":"Canadian Adult Obesity Clinical Practice Guideliens: Pharmacotherapy for Obesity Management","author":"Pedersen SDMP","year":"2022"},{"key":"e_1_2_9_49_1","volume-title":"Liraglutide for Managing Overweight and Obesity (December 2020). NICE TA664","author":"National Institute for Health and Care Excellence","year":"2021"},{"key":"e_1_2_9_50_1","unstructured":"MoodyA.Health Survey for England 2019: Overweight and obesity in adults and children.2019."},{"key":"e_1_2_9_51_1","unstructured":"European Medicines Agency.Shortage of Ozempic (semaglutide).2023. Accessed January 5 2024.https:\/\/www.ema.europa.eu\/en\/documents\/shortage\/ozempic-semaglutide-supply-shortage_en.pdf"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14538"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-016-2202-4"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12927"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24539"},{"key":"e_1_2_9_56_1","volume-title":"Mounjaro 5mg Solution for Infection in Pre\u2010filled Pen","author":"Medicines and Healthcare Products Regulatory Agency","year":"2023"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23619"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01276-7"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411892"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889\u2010020\u20108252\u20105"},{"key":"e_1_2_9_61_1","unstructured":"Guthrie S Lichten CA Leach B Pollard J Parkinson S Altenhofer M Pregnancy research review: policy report. RAND Corporation 2020. Accessed January 5 2024.https:\/\/www.rand.org\/pubs\/research_reports\/RR4340.html"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/jan.14743"},{"issue":"1","key":"e_1_2_9_63_1","first-page":"50","article-title":"Impact of GLP\u20101 agonists on male reproductive health\u2010a","volume":"60","author":"Varnum AA","year":"2023","journal-title":"Narrat Rev Med (Kaunas)"}],"container-title":["Clinical Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cob.12690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T07:15:03Z","timestamp":1732518903000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cob.12690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1111\/cob.12690"],"URL":"https:\/\/doi.org\/10.1111\/cob.12690","archive":["Portico"],"relation":{},"ISSN":["1758-8103","1758-8111"],"issn-type":[{"value":"1758-8103","type":"print"},{"value":"1758-8111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e12690"}}